Fibrinogen functions in primary haemostasis in support of platelet aggregation and in secondary haemostasis in the formation of an insoluble fibrin clot.
It is the final clotting factor activated in the coagulation cascade.
Inherited and acquired disorders can alter the quantity (afibrinogenemia and hypofibrinogenemia) and function (dysfibrinogenemia) of plasma fibrinogen.
Hypofibrinogenemia is generally asymptomatic, but afibrinogenemia and dysfibrinogenemia
may lead to bleeding and/or thrombosis.
Test based on the gold standard method, for maximum reliability
- Clauss method which is the reference method for routine tests
- Extremely reliable patient results across a large measuring range
Benefits of mechanical detection
- More reproducible than photo-optic detection in fibrinogen assays
- Insensitive to sample turbidity following massive transfusion
- No interferences from lipaemia, icterus, haemolysis
Superior analytical performance (characteristics)
- Wide working range : 0.4 -12 g/L covering any clinical situation
- Excellent precision
- correlates perfectly with STA®-Fibrinogen 5 and STA®-Fib 2
The reagent that makes life easier: results in less than 5 minutes!
- Liquid format: ready to use reagent
- Precalibrated and barcoded with standardized results across Stago analysers
Economical solution adapted to any workload through optimised reagent management
- A single 4 mL format
- Extended stability up to 10 days on-board and 2 months at 2 – 8°C
| STA®- Liquid Fib |
|---|
| Cat. Nr. 00673 |
| Pack-size: 12x 4 mL |